JFGIW
HBIO icon

Johnson Financial Group Inc (Wisconsin)’s Harvard Bioscience HBIO Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-200
Closed -$1.13K – 794
2025
Q1 		$1.13K Buy
+200
New +$2.56K ﹤0.01% 833

Other funds holding HBIO

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.46B AUM 78.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Granahan Investment Management
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s HBIO Position: Q2 2025 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Harvard Bioscience (HBIO) in Q2 2025, closing a stake of 200 shares — an estimated $1.13K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in HBIO in Q1 2025 and held it in 1 quarter. The position peaked at $1.13K in Q1 2025. 69 funds tracked by Wall St. Rank hold HBIO as of Q2 2025.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Harvard Bioscience position as of Q2 2025 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 200 Harvard Bioscience shares in Q2 2025, an estimated $1.13K.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Harvard Bioscience in Q1 2025 and held it in 1 quarter.
  • Johnson Financial Group Inc (Wisconsin)'s Harvard Bioscience position peaked at $1.13K in Q1 2025.
  • 69 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2025.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2025, filed 13 Aug 2025.